Stockscreener 앱 받기
0.524
9.81%
-0.057
시간 외 거래:
.58
0.056
+10.69%
전일 마감가:
$0.581
열려 있는:
$0.6099
하루 거래량:
2.01M
Relative Volume:
1.16
시가총액:
$67.91M
수익:
$4.75M
순이익/손실:
$-7.83M
주가수익비율:
2.407
EPS:
0.2177
순현금흐름:
$-7.24M
1주 성능:
-31.06%
1개월 성능:
-95.98%
6개월 성능:
-11.19%
1년 성능:
-21.79%
1일 변동 폭
$0.5113
$0.7222
1주일 범위
$0.5113
$0.95
52주 변동 폭
$0.46
$19.95
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
명칭
Novabay Pharmaceuticals Inc
전화
510-899-8800
주소
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
0.524 | 75.30M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-09-18 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-06 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 재확인 | Laidlaw | Buy |
| 2017-06-05 | 개시 | ROTH Capital | Buy |
| 2017-03-27 | 개시 | Laidlaw | Buy |
| 2017-02-06 | 개시 | Rodman & Renshaw | Buy |
| 2016-03-07 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-14 | 재확인 | Maxim Group | Buy |
| 2015-04-30 | 재개 | Maxim Group | Buy |
| 2013-03-06 | 개시 | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 개시 | Dawson James | Speculative Buy |
모두보기
Novabay Pharmaceuticals Inc 주식(NBY)의 최신 뉴스
What are NovaBay Pharmaceuticals Inc.’s recent SEC filings showingTrade Entry Summary & Risk Controlled Daily Plans - mfd.ru
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Up 106.1% in January - MarketBeat
NovaBay Pharma Announces 1-for-5 Reverse Stock Split - TipRanks
Reverse split shrinks NovaBay (NYSE: NBY) share count fivefold - Stock Titan
NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split - TradingView
Aug Volume: Should you avoid NovaBay Pharmaceuticals Inc stock right now2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Will NovaBay Pharmaceuticals Inc. stock sustain high P E ratiosJuly 2025 News Drivers & AI Based Buy and Sell Signals - mfd.ru
Quarterly Recap: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARMarket Risk Summary & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Massive warrant deals and share increase at NovaBay (NYSE: NBY) head to vote - Stock Titan
Profit Recap: Is NovaBay Pharmaceuticals Inc stock a top performer YTDDip Buying & Expert Curated Trade Setups - baoquankhu1.vn
Pullback Watch: Will Arko Corp benefit from government policyMarket Weekly Review & Capital Protection Trading Alerts - baoquankhu1.vn
NovaBay Pharmaceuticals appoints new auditor and announces special shareholder meeting - Investing.com India
NovaBay Pharma Schedules Special Shareholder Meeting on Warrants - TipRanks
Is NovaBay Pharmaceuticals Inc. stock a top performer YTDJuly 2025 Breakouts & Fast Moving Stock Trade Plans - mfd.ru
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Passes Below 50 Day Moving AverageHere's Why - MarketBeat
Auditor change as NovaBay (NBY) seeks approval to dissolve - Stock Titan
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Down 14.3%Should You Sell? - MarketBeat
NovaBay Pharmaceuticals enters $100 million at-the-market sales agreement By Investing.com - Investing.com Canada
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Gap DownShould You Sell? - MarketBeat
NovaBay falls on deal for $100M stock (update) (NBY:NYSE) - Seeking Alpha
NovaBay Pharmaceuticals (NBY) Announces $100M Stock Sale Agreement with Virtu Americas - intellectia.ai
Aug PostEarnings: What is NovaBay Pharmaceuticals Incs 5 year growth outlookJuly 2025 Chart Watch & Fast Gaining Stock Reports - baoquankhu1.vn
NovaBay Pharmaceuticals stock falls after $100 million ATM offering By Investing.com - Investing.com Canada
NovaBay Pharma Establishes $100 Million ATM Equity Program - TipRanks
NovaBay Pharmaceuticals enters $100 million at-the-market sales agreement - Investing.com
NovaBay Pharmaceuticals Signs ATM Sales Agreement With Virtu Americas - TradingView
Performance Recap: Does NovaBay Pharmaceuticals Inc have a sustainable dividend2025 Investor Takeaways & Daily Profit Maximizing Tips - baoquankhu1.vn
Assessing NovaBay Pharmaceuticals (NBY) Valuation After Digital Asset Financing And SKY Token Treasury Shift - Sahm
Is NovaBay Pharmaceuticals Inc stock heavily shortedWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Jobs Data: What is NovaBay Pharmaceuticals Incs 5 year growth outlookWeekly Investment Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
NovaBay Pharma Secures Crypto-Focused Financing, Shifts Strategy - The Globe and Mail
NovaBay Pharmaceuticals announces $134 million private placement of pre-funded warrants By Investing.com - Investing.com Nigeria
NovaBay Pharmaceuticals announces $134 million private placement of pre-funded warrants - Investing.com Nigeria
NovaBay Pharmaceuticals Signs Multiple Material Agreements - TradingView
NovaBay (NYSE: NBY) sells pre-funded warrants for $134M financing - Stock Titan
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Trading Up 13.2%Time to Buy? - MarketBeat
Decliners Report: Is QDWN subject to activist investor interestPortfolio Gains Report & AI Enhanced Trading Alerts - baoquankhu1.vn
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Down 8.3%Should You Sell? - MarketBeat
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Large Increase in Short Interest - MarketBeat
Buybacks Report: Can NovaBay Pharmaceuticals Inc stock sustain market leadership2025 Technical Overview & Community Verified Watchlist Alerts - Bộ Nội Vụ
Hedge Fund Bets: How supply chain issues affect NovaBay Pharmaceuticals Inc. stockMarket Growth Review & Stock Timing and Entry Methods - Bộ Nội Vụ
NovaBay: 'Hold' Rating As New M&A Direction Could Evolve But With Risks (NYSE:NBY) - Seeking Alpha
Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales - Sahm
CEO Moves: Is NovaBay Pharmaceuticals Inc subject to activist investor interestChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
NovaBay Pharmaceuticals (NBY) Stock: Why Shares Exploded 103% on Friday - Blockonomi
NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar - TechStock²
NovaBay Pharmaceuticals (NBY) Stock: Why Shares Just Doubled in One Day - CoinCentral
NovaBay stock more than doubles on thin float — what to watch for NBY when markets reopen - TechStock²
NovaBay Pharmaceuticals stock jumps 102% — what to watch for NBY before Monday - TechStock²
Assessing NovaBay Pharmaceuticals’ (NBY) Valuation After A Sharp Short Term Share Price Surge - Yahoo Finance
Novabay Pharmaceuticals Inc (NBY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.87%
자본화:
|
볼륨(24시간):